Oral Health Group

Treating Oral Disease Could Yield T2DM-Related Cost Savings

January 7, 2020
by Medical Express

Providing nonsurgical periodontal treatment to patients with type 2 diabetes (T2D) and periodontitis may significantly reduce tooth loss and diabetes-related microvascular diseases via improved glycemic control, according to a study published online Dec. 27 in Diabetes Care.

Sung Eun Choi, Ph.D., from the Harvard School of Dental Medicine in Boston, and colleagues built a microsimulation model to evaluate the cost-effectiveness of expanding periodontal treatment coverage among patients with T2D. Model inputs were derived from the U.S. National Health and Nutrition Examination Survey (2009 to 2014).

To view the full story, please click here.

Follow the Oral Health Group on Facebook, Instagram, Twitter and LinkedIn for the latest updates on news, clinical articles, practice management and more!

Print this page


Have your say:

Your email address will not be published. Required fields are marked *